FIG 2.
Cefiderocol MIC distribution of 46 multidrug- or carbapenem-resistant Pseudomonas aeruginosa isolates treated with cefiderocol under the compassionate use program. CLSI, Clinical and Laboratory Standards Institute; FDA, U.S. Food and Drug Administration.